High doses of topical amitriptyline in neuropathic pain: two cases and literature review
- PMID: 21676162
- DOI: 10.1111/j.1533-2500.2011.00477.x
High doses of topical amitriptyline in neuropathic pain: two cases and literature review
Abstract
Severe chronic neuropathic pain is a challenge to treat, and due to adverse effects of classical oral medication, optimal and effective dose levels are difficult to reach. Therefore, administration of topical analgesics might be an option, due to reduced adverse effects, and increased patient compliance. The aim of this article is to describe two cases treated effectively with topical amitriptyline 5% and 10%, the highest dosage described to date. The first patient was a 39-year-old man, suffering from severe intractable neuropathic pain in feet and hands, due to diabetes mellitus type II (DM-II). After application of amitriptyline 5% the patient experienced a complete relieve only in the hands, whereas after application of amitriptyline 10%, a total reduction of pain occurred within 20 minutes, lasting the whole day. The second patient was a 57-year-old man, suffering for 10 years from progressive sensory disturbances in both feet and increasing pain due to chronic idiopathic axonal polyneuropathy (CIAP). Amitriptyline 5% cream reduced pain in the toes nearly completely, but this was not the case in the heels. Amitriptyline 10% reduced pain in the feet, however, systemic adverse effects occurred, mainly drowsiness. The patient decided to stop topical treatment because of these adverse effects. These two cases suggest an analgesic dose-response effect of topical amitriptyline in painful neuropathy. Systemic adverse effects should be taken into account.
© 2011 The Authors. Pain Practice © 2011 World Institute of Pain.
Similar articles
-
Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study.J Pain. 2005 Oct;6(10):644-9. doi: 10.1016/j.jpain.2005.04.008. J Pain. 2005. PMID: 16202956 Clinical Trial.
-
Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.Clin J Pain. 2008 Jan;24(1):51-5. doi: 10.1097/AJP.0b013e318156db26. Clin J Pain. 2008. PMID: 18180637 Clinical Trial.
-
A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.Adv Ther. 1995 Mar-Apr;12(2):111-20. Adv Ther. 1995. PMID: 10150323 Clinical Trial.
-
Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states.Drugs Aging. 1996 Jun;8(6):459-76. doi: 10.2165/00002512-199608060-00008. Drugs Aging. 1996. PMID: 8736630 Review.
-
Topical amitriptyline and ketamine for the treatment of neuropathic pain.Expert Rev Neurother. 2015;15(11):1249-53. doi: 10.1586/14737175.2015.1101347. Epub 2015 Oct 21. Expert Rev Neurother. 2015. PMID: 26488799 Review.
Cited by
-
Topical treatments for diabetic neuropathic pain.Exp Ther Med. 2019 Mar;17(3):1963-1976. doi: 10.3892/etm.2019.7173. Epub 2019 Jan 15. Exp Ther Med. 2019. PMID: 30783472 Free PMC article. Review.
-
Topical loperamide for the treatment of localized neuropathic pain: a case report and literature review.J Pain Res. 2019 Apr 29;12:1189-1192. doi: 10.2147/JPR.S196927. eCollection 2019. J Pain Res. 2019. PMID: 31118747 Free PMC article. Review.
-
Recent Progress in Gels for Neuropathic Pain.Gels. 2023 May 16;9(5):417. doi: 10.3390/gels9050417. Gels. 2023. PMID: 37233008 Free PMC article. Review.
-
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.J Pain Res. 2012;5:437-42. doi: 10.2147/JPR.S32143. Epub 2012 Oct 26. J Pain Res. 2012. PMID: 23166447 Free PMC article.
-
Phenytoin Cream for the Treatment for Neuropathic Pain: Case Series.Pharmaceuticals (Basel). 2018 May 28;11(2):53. doi: 10.3390/ph11020053. Pharmaceuticals (Basel). 2018. PMID: 29843362 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical